Request Your Free Trend Report Now:

"The latest developments in oncology R&D"

To boost the chances of recouping the cost of innovation bets, pharma companies must leverage a multi-pronged strategy that includes picking winning medicines, using technologies like AI and bringing the right external assets into the clinical fold.

Oncology has long been pharma’s biggest bucket for R&D, with investment historically leading to some of pharma’s most impactful breakthroughs. In the coming years, innovations such as radiopharmaceuticals, new immunotherapies, and next-generation cell and gene therapies offer cutting-edge solutions in cancer care.

included in this trendline

1. Can China sustain a surge in oncology drug innovation?

• With ADCs on the rise, drugmakers embrace a new oncology pillar
• How leading oncology drugmakers set the stage for future advances

Offered Free by: PharmaVoice's studioID and Cencora
See All Resources from: PharmaVoice's studioID and Cencora